Metacrine Secures $50 Million Growth Capital Facility from K2 HealthVentures
September 18, 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Non-Alcoholic Steatohepatitis Biomarkers Market Anticipated to Garner USD 1,960.4 Million, With a CAGR of 20.92% by 2024 | MRFR
July 26, 2019 07:27 ET
|
Market Research Future
Pune, India, July 26, 2019 (GLOBE NEWSWIRE) -- The Global Non-Alcoholic Steatohepatitis Biomarkers Market Is Anticipated To Garner A Market Revenue Of USD 1,960.4 Million, At 20.92% CAGR In The...
Metacrine Doses First Patient in 12-Week NASH Proof-of-Concept Trial with a Sustained FXR Agonist
July 09, 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, July 09, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine to Present Initial Clinical NASH Data with Sustained FXR Agonist at Paris NASH Meeting 2019
July 02, 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, July 02, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine Reports Positive Interim Results with Sustained FXR Agonist in NASH Patients
May 29, 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine to Present at Jefferies 2019 Global Healthcare Conference
May 21, 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Jojoba oil Market to Reach USD 272.4 Million By 2026 | Reports And Data
April 09, 2019 12:11 ET
|
Reports And Data
Rising cosmetic industry across the globe will boost Market growth. Market Size – USD 187.8 Million in 2018, Market Growth - CAGR of 5.0%, Market Trends – The increasing use of jojoba oil in...
Algernon Pharmaceuticals Announces Reduction of Key Secondary Marker of Fibrosis in Pre-Clinical NASH Study
April 01, 2019 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
Non-Alcoholic Steatohepatitis (NASH) Market To Reach USD 13.38 Billion By 2026 | Reports And Data
February 27, 2019 08:33 ET
|
Reports And Data
Increasing prevalence of obesity coupled with rising adoption of sedentary lifestyle is the major factor influencing market growth. Market Size – USD 0.41 billion in 2018, Market Growth - CAGR of...
Nash Pharmaceuticals Announces Positive Pre-Clinical Results From a Second Study for Chronic Kidney Disease as well as 2 Additional Lead Targets
January 14, 2019 07:00 ET
|
Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI)...